These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12064823)

  • 21. Incidence and prevalence of ankylosing spondylitis in Northern Norway.
    Bakland G; Nossent HC; Gran JT
    Arthritis Rheum; 2005 Dec; 53(6):850-5. PubMed ID: 16342091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations.
    Song IH; Rudwaleit M; Listing J; Sieper J
    Ann Rheum Dis; 2009 Nov; 68(11):1701-7. PubMed ID: 19029168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fiddling while Rome burns: burn out, remission and disease activity measurements in ankylosing spondylitis.
    Thomson GT; Chalmers IM
    J Rheumatol; 1993 Apr; 20(4):607-9. PubMed ID: 8496851
    [No Abstract]   [Full Text] [Related]  

  • 24. Ankylosing spondylitis: an Australian experience.
    Reed MD; Dharmage S; Boers A; Martin BJ; Buchanan RR; Schachna L
    Intern Med J; 2008 May; 38(5):321-7. PubMed ID: 17916173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No conclusive evidence of an epidemiological relation between Klebsiella and ankylosing spondylitis.
    van Kregten E; Huber-Bruning O; Vandenbroucke JP; Willers JM
    J Rheumatol; 1991 Mar; 18(3):384-8. PubMed ID: 1856808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How should clinicians manage osteoporosis in ankylosing spondylitis?
    Bessant R; Keat A
    J Rheumatol; 2002 Jul; 29(7):1511-9. PubMed ID: 12136913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ankylosing spondylitis].
    Dougados M
    Rev Prat; 2001 Nov; 51(17):1961-7. PubMed ID: 11787231
    [No Abstract]   [Full Text] [Related]  

  • 28. Spinal mobility in ankylosing spondylitis: reliability, validity and responsiveness.
    Haywood KL; Garratt AM; Jordan K; Dziedzic K; Dawes PT
    Rheumatology (Oxford); 2004 Jun; 43(6):750-7. PubMed ID: 15163832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
    Barkham N; Kong KO; Tennant A; Fraser A; Hensor E; Keenan AM; Emery P
    Rheumatology (Oxford); 2005 Oct; 44(10):1277-81. PubMed ID: 16105913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of the minimum clinically important difference for the bath ankylosing spondylitis indices: a prospective study.
    Pavy S; Brophy S; Calin A
    J Rheumatol; 2005 Jan; 32(1):80-5. PubMed ID: 15630730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis.
    Maksymowych WP; Richardson R; Mallon C; van der Heijde D; Boonen A
    Arthritis Rheum; 2007 Feb; 57(1):133-9. PubMed ID: 17266072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging in ankylosing spondylitis.
    Zochling J; Baraliakos X; Hermann KG; Braun J
    Curr Opin Rheumatol; 2007 Jul; 19(4):346-52. PubMed ID: 17551364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ankylosing spondylitis in tribal belt of Chhotanagpur region.
    Prasad P; Singh RP
    J Indian Med Assoc; 1982 Apr; 78(7):108-12. PubMed ID: 7119457
    [No Abstract]   [Full Text] [Related]  

  • 34. Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis.
    Tubach F; Pham T; Skomsvoll JF; Mikkelsen K; Bjørneboe O; Ravaud P; Dougados M; Kvien TK
    Arthritis Rheum; 2006 Dec; 55(6):960-3. PubMed ID: 17139643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept.
    Davis JC; Van der Heijde DM; Dougados M; Braun J; Cush JJ; Clegg DO; Inman RD; de Vries T; Tsuji WH
    J Rheumatol; 2005 Sep; 32(9):1751-4. PubMed ID: 16142873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system.
    Braun J; Baraliakos X; Golder W; Brandt J; Rudwaleit M; Listing J; Bollow M; Sieper J; Van Der Heijde D
    Arthritis Rheum; 2003 Apr; 48(4):1126-36. PubMed ID: 12687557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaptation of the Bath measures on disease activity and function in ankylosing spondylitis into Danish.
    Pedersen OB; Hansen GO; Svendsen AJ; Ejstrup L; Junker P
    Scand J Rheumatol; 2007; 36(1):22-7. PubMed ID: 17454931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Endothelial dysfunction in patients with Bechterew's disease (ankylosing spondylitis)].
    Poddubnyĭ DA; Rebrov AP
    Klin Med (Mosk); 2007; 85(7):66-9. PubMed ID: 17882816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self- and manual mobilization improves spine mobility in men with ankylosing spondylitis--a randomized study.
    Widberg K; Karimi H; Hafström I
    Clin Rehabil; 2009 Jul; 23(7):599-608. PubMed ID: 19403551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional impairment in spondyloarthropathy and fibromyalgia.
    Heikkilä S; Ronni S; Kautiainen HJ; Kauppi MJ
    J Rheumatol; 2002 Jul; 29(7):1415-9. PubMed ID: 12136899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.